FDA Proposes PMAs For Metal-On-Metal Hips
This article was originally published in The Gray Sheet
Executive Summary
Spurred by heightened adverse event and revision rates, FDA is proposing enhanced pre-market requirements for all metal-on-metal hip implants.
You may also be interested in...
PMAs Are The New Reality For Metal-On-Metal Hips
A final order from FDA calls for manufacturers to submit PMAs or take their metal-on-metal hip devices off the market by May 18. The widely anticipated move is part of a broader response to elevated adverse event rates tied to the products.
Consumers Union Renews Push For Hip, Knee Implant Warranties
The consumer advocacy group is launching a campaign to press hip and knee implant makers to offer long-term warranties on their products. Currently, only one partial knee replacement implant offers consumers financial protection against failure.
FDA Calling For More PMAs Than 510(k)s In Final Set Of Preamendment Devices
“The Gray Sheet” reviewed CDRH’s proposed orders and final classification decisions on preamendment devices targeted by the 515 initiative. As of Aug. 5, FDA has proposed or finalized 14 PMAs, and proposed or finalized 10 products to be downclassified to class II with special controls.